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Abstract
Intestinal immune cells are important in host defense, yet the determinants for human lymphoid
homeostasis in the intestines are poorly understood. In contrast, lymphoid homeostasis has been
studied extensively in mice, where the requirement for a functional common γ-chain molecule has
been established. We hypothesized that humanized mice could offer insights into human intestinal
lymphoid homeostasis if generated in a strain with an intact mouse common γ-chain molecule. To
address this hypothesis, we used three mouse strains (non-obese diabetic (NOD)/severe-combined
immunodeficient (SCID) (N/S); NOD/SCID γ-chain−/− (NSG); and Rag2−/− γ-chain−/− (DKO))
and two humanization techniques (bone marrow liver thymus (BLT) and human CD34+ cell bone
marrow transplant of newborn mice (hu)) to generate four common types of humanized mice: N/
S-BLT, NSG-BLT, NSG-hu, and DKO-hu mice. The highest levels of intestinal human T cells
throughout the small and large intestines were observed in N/S-BLT mice, which have an intact
common γ-chain molecule. Furthermore, the small intestine lamina propria T-cell populations of
N/S-BLT mice exhibit a human intestine-specific surface phenotype. Thus, the extensive intestinal
immune reconstitution of N/S-BLT mice was both quantitatively and qualitatively better when
compared with the other models tested such that N/S-BLT mice are well suited for the analysis of
human intestinal lymphocyte trafficking and human-specific diseases affecting the intestines.
INTRODUCTION
Despite the importance of intestinal immune cells in host defense against luminal pathogens,
little is known regarding the factors that contribute to human lymphoid homeostasis in the
intestines in health or in disease. Extensive research on the gastrointestinal immune system
in mice has led to significant progress in our understanding of the molecular basis of
intestinal reconstitution with immune cells. In particular, the interleukin (IL)-2 receptor
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(common) γ-chain has been found to be essential for the population of the mouse intestines
with lymphoid cells.1–6 Yet, it remains unknown whether human cells depend on the
common γ-chain for efficient trafficking of lymphoid cells into the intestines and for the
establishment of gut-associated lymphoid tissue. As human and mouse intestines are closely
related in both anatomy and physiology,7 we utilized humanized mice to address this
question in a model where human T-cell trafficking into the intestines could be examined in
vivo. Humanized mice are immunodeficient animals harboring human immune cells
generated in situ as a result of a human CD34+ hematopoietic stem cell bone marrow
transplant. Humanized mice serve as a useful research platform to probe human intestinal
development questions that cannot be addressed directly in humans.
The transplantation of human CD34+ hematopoietic stem cells into severe-combined
immunodeficient (SCID) or non-obese diabetic (NOD)/SCID mice resulted in de novo
generation of human B cells, monocytes/macrophages, and dendritic cells.8,9 A major
limitation of these humanized mouse models, however, was the total absence of human T
cells.8 Additional immunodeficient mouse strains were developed that lacked the mouse
common γ-chain that is required for signaling through the mouse IL-2, IL-4, IL-7, IL-9,
IL-15, and IL-21 receptors.10–18 As with NOD/SCID (N/S) mice, common γ-chain-deficient
mice (NOD/SCID γ-chain−/− (NSG) and Rag2−/− γ-chain−/− (DKO)) are efficiently
engrafted by human CD34+ cells that give rise to human B cells, monocytes/macrophages,
and dendritic cells. Importantly and in contrast to N/S mice, NSG and DKO mice are
capable of supporting human T-cell development.10–18
The development of humanized mice harboring de novo generated human T cells was a
major advance in the field, but it should be noted that in these models human T cells are
produced in the context of a mouse thymus with epithelial cells expressing mouse major
histocompatibility complex molecules. A third generation of humanized mice was then
developed that included the presence of a bona fide human thymus.19,20 These mice are
created by performing a bone marrow transplant of autologous human CD34+ cells into mice
implanted with autologous human liver and thymus tissue under the kidney capsule (as with
SCID-hu thymus and liver mice).19–21 In bone marrow liver thymus (BLT) mice, human B
cells, monocytes/macrophages, dendritic cells, and thymocyte precursors are produced by
the bone marrow, whereas human T cells are generated in the implanted human thymus. In
these mice, the human thymocytes produced in the context of a human thymic epithelium
become T cells that are capable of mounting human leukocyte antigen-restricted immune
responses.20,22,23
In mice, the importance of the mouse common γ-chain for intestinal lymphoid tissue
development has been definitively shown; mice lacking the common γ-chain do not develop
gut-associated lymphoid tissue when compared with wild-type animals.1–6 Nevertheless,
human hematopoietic stem cell transplantation of such strains results in high levels of
human cell engraftment, a characteristic highly desirable for the production of humanized
mice.24,25 We hypothesized that an unintended consequence of the humanization of mice
lacking the common γ-chain molecule would be inefficient reconstitution of the humanized
mouse intestines with human T cells. To address this question, we generated four types of
humanized mice extensively used in biomedical research: three that are based on common
γ-chain-deficient mice and one that is based on a mouse strain with an intact common γ-
chain (Figure 1). We then examined their intestines to compare directly the levels of
reconstitution with human T cells between models. Consistent with our hypothesis, the
results of this comparison are that the highest immune reconstitution of the mouse intestines
with human T cells is observed in mice expressing the common γ-chain molecule.
Furthermore, we also observed that the presence of a human thymus further improves the
levels of reconstitution of the mouse intestines with human T cells.
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Humanized mice are generated in several different mouse strains by multiple techniques
(Figure 1). NOD/SCID, NSG, and DKO are the three immunodeficient mouse strains most
frequently used for the production of humanized mice and each has specific technical
requirements for achieving the maximum human engraftment possible. Therefore, we
implemented previously optimized and published techniques for generating maximal human
engraftment in each of the different humanized mice utilized here to produce the highest
likelihood of observing intestinal human T-cell reconstitution in each type of humanized
mouse examined.11,12,20,26–32 Human CD34+ hematopoietic stem cell transplantation into
preconditioned recipients is a common aspect of the techniques employed for generating the
humanized mice tested here.25 However, to generate BLT mice, the human CD34+ cell
transplant is performed in conjunction with surgical implantation of autologous fetal thymus
and liver tissue that develops into a bona fide human thymus under the mouse kidney
capsule.19,20 In total, we generated four of the most commonly utilized types of humanized
mice: N/S-BLT, NSG-BLT, NSG-hu, and DKO-hu (Figure 1).24,25
Regardless of mouse strain or humanization protocol, the human CD34+ cells that engraft
the bone marrow of humanized mice are known to give rise to human T, B, monocytes/
macrophages, natural killer, and dendritic cells that systemically repopulate these
animals.24,25 For the humanization analyses presented in this manuscript (Tables 1 –3), we
examined 27 humanized mice (N/S-BLT, n=6; NSG-BLT, n=10; NSG-hu, n=7; and DKO-
hu, n=4). The average peripheral blood human CD45-expressing cells among these mice
was 33% (2–86% range; n=27). Consistent with previous reports,24,25 we observed human
hematopoietic cells, including CD3+ T cells, in bone marrow, spleen, liver, and lungs of N/
S-BLT, NSG-BLT, NSG-hu, and DKO-hu mice (Table 1 and Figure 2a). Mann–Whitney U
-test comparisons were performed comparing the absolute numbers of human T cells found
in the four types of humanized mice within each of the tissues analyzed (Table 1). Of these
24 tests conducted, eight comparisons showed significant differences between groups. Seven
of the eight tests revealed statistically significant lower levels of humanization in DKO-hu
mice relative to the other three types of humanized mice. Between the NSG-hu, NSG-BLT,
and N/S-BLT mice, there were fewer differences in human T-cell levels in these tissues.
These comparisons presented in Table 1 confirm previously published humanization
comparison data with related humanized mice.33 Taken together, these results demonstrate
the presence of human reconstitution in primary lymphoid organs and secondary lymphoid
organs, liver and lungs in these four types of humanized mice regardless of whether the
human T cells were produced in a human or a mouse thymus (Figure 3).
The mouse strain, combined with humanization protocol, determines whether there is the
potential for human T-cell production to occur only in a human thymus, only in a mouse
thymus, or in both the human thymus and mouse thymus within the same mouse (Figure 3).
Both the human thymus and the mouse thymus in humanized mice generate diverse T-cell
receptor (TCR) Vβ repertoires.18,20,34 Thus, the impacts of the specific thymus or thymuses
functioning in a particular type of humanized mouse are based on the total number of
thymocytes present (Table 2) and also on T-cell education. Specifically, the thymic stroma
differs between human and mouse thy-muses, resulting in either human leukocyte antigen-
restricted and/or mouse major histocompatibility complex-restricted human T cells
depending on the specific humanized mice analyzed.16,20,22,23 While only the mouse thymus
is present in NSG-hu and DKO-hu mice,10,16–18 N/S-BLT and NSG-BLT mice have an
implanted human thymus where human T cells are produced (Figure 3).20,22,23 N/S-BLT
mice have a vestigial mouse thymus devoid of lymphocytes; thus, all human T cells are
produced by the implanted human thymic organoid.20 The NSG-BLT mice present an
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interesting situation because human T cells can be produced in a human or a mouse thymus
in parallel in the same mouse (Figure 3).
Given the critical contribution of mesenteric lymph nodes to immune cell migration into the
intestines,35,36 we examined the ability of the human cells to populate the mesenteric lymph
nodes in each of these types of humanized mice. Human cells were found throughout the
mesenteric lymph nodes of mice from all four models (Figure 2b). We then proceeded to
determine whether human cells are present in the intestines in each of the four different
types of humanized mice. Human cells were readily detected in the small (SI) and large
intestines (LI) of N/S-BLT mice (Figure 2c and d). Similarly, the SI and LI of NSG-BLT
and NSG-hu mice were found to harbor human CD45+ hematopoietic cells (Figure 2c and
d). In contrast, human cells in the intestines of DKO-hu mice were rarely observed (Figure
2c and d).
Effector sites of the SI and LI include the lamina propria and the single layer of epithelium
adjacent to the lumen supported by the lamina propria. Lymphocytes found within these
sites are referred to as either lamina propria lymphocytes (LPL) or intraepithelial
lymphocytes (IEL) based on their location. We determined the numbers of human T cells in
the entire gut and in each of these intestinal compartments: SI LPL, SI IEL, LI LPL, and LI
IEL. There were clear differences in the intestinal human T-cell levels noted between the
different types of humanized mice analyzed with the N/S-BLT mice exhibiting the highest
levels of intestinal human T cells of all humanized mouse groups (Table 3). Taken together,
the immunohistochemistry and flow cytometry analyses confirm differences in human T-cell
engraftment of the intestines of different types of humanized mice (Figure 2c and d and
Table 3).
The data obtained from the intestinal analyses demonstrate that N/S-BLT mice exhibit high
and consistent levels of human T cells throughout all the intestinal fractions (Table 3). N/S
mice have wild-type mouse common γ-chain, but NSG mice are deficient for this gene
(Figure 1). Both N/S-BLT and NSG-BLT mice have a human thymus (Figure 3 and Table
2). Our data show that the intestines of N/S-BLT and NSG-BLT mice harbor similar levels
of human T cells in the SI LPL, but not the LI LPL (Table 3). In addition, the levels of T
cells in the N/S-BLT SI IEL and LI IEL are significantly higher than those observed in
NSG-BLT intestines (Table 3), which may reflect increased proliferation or longer survival
of human T cells in the IEL space of N/S-BLT mice. Regardless of the mechanism, these
significant differences demonstrate the critical requirement for the mouse common γ-chain
in obtaining robust levels of human intestinal T cells in humanized mice, as observed in N/
S-BLT mice.
As indicated above, NSG-hu mice only have a mouse thymus, whereas NSG-BLT mice have
a human and a mouse thymus (Figure 3). The most notable effect of this difference is the
significantly higher level of human T cells in the SI LPL fraction found in NSG-BLT mice
(Table 3). Comparisons of the absolute numbers of intestinal human T cells found in NSG-
BLT to NSG-hu mice revealed that the human T-cell levels were different in the SI LPL and
LI IEL, but not in the SI IEL or LI LPL (Table 3). Furthermore, DKO-hu mice had the
lowest levels of human T cells in the SI LPL, SI IEL, LI LPL, and LI IEL when compared
with N/S-BLT, NSG-BLT, and NSG-hu mice. Taken together, these data indicate that both
the presence of a human thymus and the presence the γ-chain molecule contribute to higher
levels of human T cells in the intestines of humanized mice.
In addition to the contributions from the mouse common γ-chain and the human thymus,
another contributing factor in the reconstitution of the mouse intestines with human T cells
could be differences in the expression of homing molecules that direct T cells to the
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intestines. In mice, α4β7 integrin has been shown to play an important role in T-cell
trafficking to the intestines.7,37,38 In humans, peripheral blood T cells frequently express α4
and β7 on their surface and these two integrin subunits form a heterodimer in the presence of
retinoic acid imprinting them for trafficking into the intestines.39 β7 Expression on the
surface of peripheral lymphocytes is an established marker to demonstrate the potential for
intestinal homing of human T cells.40 We therefore determined the levels of human
CD8+β7+ and CD4+β7+ T cells in each type of humanized mice (Figure 4). We examined β7
expression because antibodies specific for the human α4β7 heterodimer are not available and
co-expression of α4 and β7 on the surface of any given cell does not indicate whether the
α4β7 heterodimer is actually present. We observed comparable levels of β7+ human T cells
in all four types of humanized mice (Figure 4). The similar levels of β7+ human T cells in all
types of humanized mice indicates that differences in homing receptor expression among
humanized mice is likely not responsible for the different levels of human T cells present in
the intestines.
We sought to determine the extent that human T cells in humanized mouse intestines are
similar to intestinal T cells in normal human gut. Since the highest human T-cell
reconstitution levels occurred in N/S-BLT and NSG-BLT mice, we focused these detailed
analyses in the SI of these two types of humanized mice. We previously reported that the
human intestinal T cells in N/S-BLT mice29 and NSG-BLT mice28 exhibit a memory
surface phenotype just as in human intestines, leading us to explore additional phenotypes to
be compared between these BLT mice and human intestines. Intestinal flora is present in
normal humans, but their intestinal T cells do not produce effector molecules (e.g., perforin,
granzyme B).41 Similarly, we observed no perforin or granzyme B production in the SIs of
N/S-BLT and NSG-BLT mice using a similar immunohistochemistry approach to that
reported for the human studies. Thus, the intestinal T cells in these humanized mice are
acting in a manner analogous to a normal human gut, suggesting that they are tolerized to
the intestinal flora recapitulating a critical human intestinal T-cell phenotype. Next, we
examined the TCR Vβ repertoire in the SIs of these humanized mice. Given that their
intestinal mucosa and submucosa is comprised of a mixture of mouse epithelial cells, mouse
stromal cells, and human leukocytes, this environment could result in the skewing of T-cell
populations. This appeared not to be the case as our results show that the human TCR Vβ
repertoire in the SI IEL and SI LPL fractions of both N/S BLT and NSG-BLT mice were
polyclonal, as has been described in young humans (Figure 5).42 For a third comparison
between normal human intestinal T cells and those in humanized mice, we took advantage
of the fact that human intestinal T cells have an unambiguous surface phenotype that
distinguishes them from human T cells in other tissues in the body. Specifically, on the
surface of the CD8+CD4− T cells in the human SI, the CD8 receptor is typically a
heterodimer composed of a CD8α molecule plus a CD8β molecule; however, on the surface
of human intestinal CD8+CD4+ T cells, the CD8 receptor is typically composed of a
homodimer of two CD8α chains (CD8αα).43,44 We found that the expression of CD8αα on
CD8+CD4+ T cells described in human intestines is also observed on the SI LPL and SI IEL
cells in N/S-BLT mice (Figure 6a, c, and d). In contrast, cells expressing this homodimer
were essentially absent from NSG-BLT mice (Figure 6b–d). Given that both N/S-BLT and
NSG-BLT mice have a human thymus, this observation indicates that the mouse common γ-
chain molecule contributes to the reconstitution of the N/S-BLT mouse intestines with the
same human T-cell populations that are present in human intestines.
DISCUSSION
Intestinal immune cells are a critical component of a normal human immune system and the
availability of a small animal model where the intestines are populated with human T cells
will aid in the study of human intestinal immune development, intestinal lymphocyte
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trafficking, and the pathogenesis of human diseases affecting the intestines.7 To determine if
humanized mice could help fill this need, we conducted a comparative study of human T-
cell reconstitution in the intestines of four of the most commonly utilized types of
humanized mice: N/S-BLT, NSG-BLT, NSG-hu, and DKO-hu mice.24,25
DKO-hu mice were the first humanized mouse model where the transplant of human CD34+
cells was shown to result in systemic population with de novo generated human T cells.15,18
This frequently utilized humanized mouse model24,25 has been shown to harbor human
intestinal immune cells,12,32 although this finding has been contradicted.14 We directly
addressed this conflicting literature by examining the intestinal human reconstitution in
DKO-hu mice. To maximize the potential for identifying human reconstitution in DKO-hu
mice, we cultured the CD34+ cells overnight in cytokines before transplantation into DKO
mouse pups according to the protocols reporting the highest levels of intestinal immune
reconstitution in this model.11,12,32 We identified human T cells in DKO-hu mouse bone
marrow, spleen, liver, mesenteric LN, and lungs, a mucosal tissue distinct from the
intestines (Table 1 and Figure 2a and b). However, it is important to note that very few
human intestinal T cells were identified in DKO-hu mice (Figure 2c and d and Table 3).
When compared with NSG-hu mice, the intestinal human T-cell reconstitution of DKO-hu
mice was lower (Figure 2c and d and Table 3). Similarly, human T-cell levels also differed
between DKO-hu and NSG-hu mice in the bone marrow, liver, and lungs (Table 1). These
results confirm previously published data showing that immunodeficient mice derived from
BALB/c backgrounds humanize less efficiently relative to those derived from NOD
backgrounds, likely due to signal regulatory protein α polymorphisms between the founder
strains.33,45–47 In addition to DKO-hu and NSG-hu mice, we also determined the intestinal
human T-cell levels in two distinct BLT humanized mice generated in immunodeficient
strains derived from NOD founders, NSG-BLT and N/S-BLT mice.
NSG-BLT and NSG-hu mice are generated in the same immunodeficient mouse strain
lacking the mouse common γ-chain molecule (NSG). This critical distinction permits a
determination of the effect of BLT humanization on intestinal T-cell levels. We found that
these two types of humanized mice have comparable human T-cell levels in their spleen,
liver, and lungs (Table 1). While both NSG-BLT and NSG-hu mice have been reported to
have intestinal human T cells,13,28 our comparison revealed that there are more human T
cells in the SI LPL fractions of NSG-BLT vs. NSG-hu mice (Table 3). Importantly, NSG-
BLT SI human T cells did not exhibit a human gut-specific phenotype (i.e., CD8αα+CD4+)
(Figure 6b–d). The difference in the levels of SI LPL human T cells between NSG-BLT and
NSG-hu is likely due to the greater number of human T cells trafficking throughout their
body including the mesenteric LN that contribute to the SI LPL population (Table 2 and
Figure 2b).35,36 The uniqueness of this pair of humanized mice highlights how in NSG mice
the human thymus can contribute to higher levels of intestinal T cells, but not their gut-
specific phenotype.
Both N/S-BLT and NSG-BLT mice have a human thymus, but only N/S-BLT mice express
the mouse common γ-chain molecule. This critical distinction permitted determination of
the effect of the mouse common γ-chain on intestinal T-cell levels. We found that these two
types of humanized mice have comparable human T-cell levels in their bone marrow,
spleen, liver, lungs, and SI LPL (Tables 1 and 3). We also found that, as in young humans,
the SI IEL and SI LPL TCR Vβ repertoires were polyclonal in both N/S-BLT and NSG-BLT
mice (Figure 5).42 However, we observed more human T cells in the SI IEL, LI LPL, and LI
IEL fractions of N/S-BLT mice vs. NSG-BLT mice (Table 3). Furthermore, only N/S-BLT
mice contain human intestinal CD8αα+CD4+ T cells (Figure 6).43,44 These differences
between N/S-BLT and NSG-BLT mice cannot be explained by differential expression of the
β7 integrin component of the intestinal homing receptor, α4β7 (Figure 4). Thus, the
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uniqueness of this pair of humanized mice emphasizes the critical nature of the mouse
common γ-chain for recruiting human gut-specific T cells into the intestines of humanized
mice. The function of the mouse common γ-chain molecule in intestinal immune
development provides a putative mechanistic explanation for our observations. Specifically,
the mouse common γ-chain molecule is a required component of the mouse IL-7 receptor,
which plays an indispensible role in the earliest stages of intestinal immune development.1–6
Development of the intestinal immune system begins when mouse intestinal epithelial cells
produce IL-7 triggering production of lymphotoxins by lymphoid tissue inducer-like
cells.1,2,48 Lymphotoxin expression leads to an upregulation of the expression of adhesion
molecules and chemokines from stromal lymphoid tissue organizer cells that recruit
lymphocytes to this site.1,2,48 In the immunodeficient mice lacking lymphocytes used to
generate humanized mice, this process can only occur after the engrafted human immune
system begins to generate human lymphocytes. Without an intact IL-7 receptor on the
lymphoid tissue inducer-like cells, as occurs in IL-2Rγ−/−-deficient mice, there is no gut
immune development because there is no response to the initial IL-7 produced by intestinal
epithelial cells.1–6 Thus, the general paucity of human intestinal T cells observed in the
humanized mice generated in common γ-chain-deficient mice (NSG and DKO) is
attributable primarily to the absence of the common γ-chain molecule. The integral nature
of the mouse common γ-chain molecule in development of the intestinal immune system
clarifies why the most robust and human-like intestinal humanization is observed in N/S-
BLT mice and why there are both quantitative and qualitative differences in the intestinal
human T-cell reconstitution of N/S-BLT, NSG-BLT, NSG-hu, and DKO-hu mice. These
results predict that BLT humanized mice generated in additional strains containing an intact
mouse common γ-chain (e.g., NOD/Rag1−/−) would also exhibit robust intestinal T-cell
reconstitution.
In conclusion, we found that BLT mice generated in the NOD/SCID strain that contains an
intact mouse common γ-chain exhibited the most robust and consistent intestinal immune
cell engraftment. In addition, we report that in NSG-BLT mice there are two different
sources of human T cells: the mouse thymus and the implanted human thymic organoid.
This observation has potentially significant implications for the use of this model to study T-
cell function, as T cells are being simultaneously produced in the context of both human and
mouse thymic epithelium. The extensive intestinal humanization of N/S-BLT mice and the
single source of human T cells produced in the context of a human thymic epithelium make
this model an excellent system in which to gain understanding of intestinal lymphocyte
trafficking as well as pathogenesis of human-specific diseases affecting the intestines.
METHODS
Generation of humanized mice
Our experimental aim was to identify the best humanized mouse model available for the
study of intestinal human T-cell levels. Therefore, humanized mice were prepared using
published protocols for generating the maximal human engraftment in each type of
humanized mice utilized here 11,12,20,26–32 (Figure 1). Human fetal liver (Advanced
Bioscience Resources, Alameda, CA)-derived CD34+ cells were isolated using magnetic
positive selection. CD34+ cell preparations were analyzed for the presence of human T cells
before transplantation (CD3+ cells=0.5% mean; 0–1.3% range) (Supplementary Figure S1
online). BLT mice were generated as described previously.20,26,28,29 Briefly, CD34+ cells
were transplanted into preconditioned autologous liver and thymus tissue implanted N/S or
NSG mice (NOD.CB17-Prkdcscid/J and NOD.Cg-PrkdcscidIl-2rgtm1Wjl/SzJ, respectively;
both from The Jackson Laboratories, Bar Harbor, ME). N/S mice were preconditioned with
325 cGy γ-radiation and transplanted with up to 3×106 CD34+ cells. Similarly, NSG mice
were preconditioned with 300 cGy γ-radiation and also transplanted with up to 3×106
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CD34+ cells. This process resulted in the generation of either N/S-BLT or NSG-BLT mice,
depending on the specific mouse strain utilized. CD34+ cell transplant-only humanized NSG
mice (NSG-hu) were generated as described previously.30,31 Briefly, up to 3 × 105 purified
fetal liver CD34+ cells were injected intrahepatically into 100 cGy preconditioned newborn
NSG pups. DKO mice (BALB/c-Rag2−/− γc−/−; DKO) were transplanted with CD34+ cells
to generate humanized-DKO (DKO-hu) mice as described previously.11,12,32 Briefly,
purified fetal liver CD34+ cells were cultured overnight in RPMI 1640 medium containing
IL-3, IL-6, and stem cell factor (1, 1, and 2 μgml−1, respectively) before intrahepatic
injection into 400 cGy preconditioned newborn to 3-day-old DKO pups (up to 5×105 cells).
All mice were maintained either at the Animal Resources Center of the University of Texas
Southwestern Medical Center at Dallas or at the Division of Laboratory Animal Medicine at
the University of North Carolina at Chapel Hill in accordance with protocols approved by
each institution’s Institutional Animal Care and Use Committee.
Sample preparation and flow cytometric characterization of human reconstitution
Whole peripheral blood from humanized mice was monitored for human reconstitution
according to the BD Biosciences Lyse/Wash protocol (Cat. No. 349202) as we have
described previously.20,28,29 Following antibody labeling of whole blood, red blood cells
were lysed. The remaining cells were washed, fixed, and the sample was analyzed by flow
cytometry. Tissue mononuclear cell isolations were also performed according to published
methods.20,28,29 The absolute numbers of human cells from each type of humanized mouse
were calculated by multiplying the total number of cells collected from the indicated tissues
by the respective flow cytometry determined cell population percentages. For all flow
cytometry analyses, sequential gating of each sample was utilized as described
previously.20,28,29 In brief, forward and side scatter properties of the samples were used to
gate live cells. Within this gate, all cells expressing the human pan-leukocyte marker CD45+
were gated and subsequent gates were then used to identify human CD3+ T cells. Subsets of
CD3+ cells were identified based on CD4 and/or CD8 expression. In peripheral blood,
human T-cell subsets were examined for human β7 expression as described previously.40 In
the SI lamina propria, human T-cell subsets were examined for CD8α and CD8β molecule
expression as we described previously.29 This analysis was performed via gating through
human CD3ε+ cells (α-CD3ε clone: SK1) that would permit the detection of both α–β T
cells and γ–δ T cells that may be present; however, it should be noted that previous analyses
were unable to detect γ–δ cells.29 Cytometry data were collected using a BD FACSCanto
cytometer and analyzed using the BD FACSDiva software (v.5.0.2, San Jose, CA).
TCR Vβ repertoire analysis
Immunoscope analysis was performed as described previously to determine the TCR
diversity in pooled SI IEL and pooled SI LPL harvested from N/S-BLT (n=4) and NSG-
BLT (n=7) mice.49,50 Briefly, cDNA was prepared from each of the four samples and real-
time polymerase chain reaction performed by combining primers for the different Vβ chains
(Vβ2–30). Fluorescent products were separated on ABI-Prism 3730 DNA analyzer to
determine CDR3 lengths.49,50
Sample preparation and immunohistochemical characterization of human reconstitution
The harvested tissues were fixed with 4% para-formaldehyde (Sigma, St Louis, MO)
overnight and then embedded in paraffin (Leica, Newcastle, UK). Tissue sections (5 μm)
were mounted on poly-L-lysine-coated glass slides (Electron Microscopy Sciences, Hatfield,
PA) and then dewaxed. Antigen retrieval was performed by heating sections in Diva
Decloacker (Biocare Medical, Concord, CA) at 95 °C for 30 min. The sections were
incubated with mouse anti-human CD45 (1μg ml−1, clone 2B11+PD7/26; Dako, Glostrup,
Denmark) or control mouse IgG1 (1 μg ml−1, clone X 0931; Dako) overnight at 4°C after
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blocking with Background Sniper (Biocare Medical) for 30 min. Endogenous peroxidase
was then blocked with 3% (vv−1) H2O2. After washing, the sections were treated with
MACH 3 Mouse Probe (Biocare Medical) for 10 min, followed by MACH 3 Mouse HRP-
Polymer (Biocare Medical) for 10 min. The sections were then treated with ImmPACT DAB
(Vector, Burlingame, CA) to develop the signals and finally counterstained with
hematoxylin (Sigma).
Statistics
All statistical analyses were performed in Prism v.4 (Graph Pad, La Jolla, CA). Mann–
Whitney U-tests were utilized to determine differences between groups in Tables 1–3 and
Figures 4 and 6.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Schematic representation of the strains and humanization protocols utilized to generate
humanized mice for this comparative analysis. The top row depicts the three
immunodeficient mouse strains that were used for this analysis. Non-obese diabetic (NOD)/
severe-combined immunodeficient (SCID) (N/S) mice have an intact mouse γ-chain
molecule, whereas NOD/SCID 3-chain−/− (NSG) and Rag2−/− γ-chain−/− (DKO) mice lack
the mouse common γ-chain. Each strain was preconditioned with the optimized dose of
radiation before the transplant of human CD34+ cells as part of either the bone marrow liver
thymus (BLT) or transplant-only humanization protocols shown. The identifying label
associated with each of the four humanized mice analyzed is indicated.
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Human engraftment is similar in the lungs and mesenteric lymph nodes (LNs) of non-obese
diabetic (NOD)/severe-combined immunodeficient (SCID)-bone marrow liver thymus (N/S-
BLT), NOD/SCID γ-chain−/− (NSG)-BLT, NSG-human CD34+ cell bone marrow transplant
of newborn mice (hu), and Rag2−/− γ-chain−/− (DKO)-hu mice, but intestinal human
engraftment differs between these groups. (a–d) Immunohistochemistry was used to identify
human cells in the lungs, mesenteric lymph nodes, and intestines of humanized mice. (a, b)
Human CD45+ hematopoietic cells are present in the lung (a) and the mesenteric LNs (b) of
each type of humanized mouse. (c, d) Human CD45+ cells were readily detected in the
intestines of N/S-BLT, NSG-BLT, and NSG-hu mice, but not in the intestines of DKO-hu
mice (Bar = 100 μm). Lg, large; Sm, small.
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The humanization strategy and mouse strain determine whether a mouse thymus, a human
thymus, or both are present, wherein human T cells are produced. In non-obese diabetic
(NOD)/severe-combined immunodeficient (SCID)-bone marrow liver thymus (N/S-BLT)
mice, all human T cells are produced in the human thymic organoid. NOD/SCID γ-chain−/−
(NSG-BLT) mice have both a human thymic organoid and a mouse thymus. NSG-human
CD34+ cell bone marrow transplant of newborn mice (hu) and Rag2−/− γ-chain−/− (DKO)-
hu mice have only the mouse thymus as they do not contain surgically implanted human
tissues. The ages of the human grafts at the time of analysis were between 13 and 23 weeks
post-transplant. Table 2 provides absolute numbers of human thymocytes present in each
type of humanized mouse shown in this figure.
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Non-obese diabetic (NOD)/severe-combined immunodeficient (SCID)-bone marrow liver
thymus (N/S-BLT), NOD/SCID γ-chain−/− (NSG)-BLT, NSG-human CD34+ cell bone
marrow transplant of newborn mice (hu), and Rag2−/− γ-chain−/− (DKO)-hu mice have
comparable levels of β7+ blood T cells. All humanized mice examined harbor human CD4+
β7+ and CD8+ β7+ T cells in their peripheral blood indicating their potential to traffic to the
intestines. In all, 12 Mann–Whitney U-tests were performed comparing results from the four
types of humanized mice, of which 10 tests showed no significant difference (α = 0.05;
unmarked). The two comparisons yielding significant differences are represented by a line
connecting the arrows above the respective bars (*P < 0.05; **P < 0.01).
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T-cell receptor (TCR) Vβ repertoires are diverse in the small intestines (SIs) of non-obese
diabetic (NOD)/severe-combined immunodeficient (SCID)-bone marrow liver thymus (N/S-
BLT) and NOD/SCID γ-chain−/− (NSG)-BLT mice. (a–d) Immunoscope analysis of pooled
SI intraepithelial lymphocytes (IEL) and SI lamina propria lymphocytes (LPL) fractions of
(a, c) N/S-BLT (n = 4) (b, d) NSG-BLT (n = 7) revealed a polyclonal TCR Vβ repertoire in
each fraction analyzed. Notably, each Vβ from 2 to 30 was identified in each intestinal
fraction examined. Pie charts detail the relative proportions of each Vβ to the total number
of amplicons within each fraction.
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CD8αα+ CD4+ human T cells are present in the small intestine (SI) of bone marrow liver
thymus (N/S-BLT) mice, but not NOD/SCID γ-chain−/− (NSG)-BLT mice. (a) As in
humans, N/S-BLT mouse CD8+ CD4+ human T cells from the SI lamina propria primarily
express an intestine-specific CD8αβ homodimer, while the CD8+ CD4− human T cells
typically express the CD8αβ heterodimer. (b) Unlike in humans, NSG-BLT mouse SI
lamina propria human T cells primarily express CD8αβ heterodimers on both CD8+ CD4+
and CD8+ CD4− cells. (c) CD8αα homodimer expression was similar on CD8+ CD4− T
cells of the SI lamina propria lymphocytes (LPL) and SI intraepithelial lymphocytes (IEL)
fractions from N/S-BLT and NSG-BLT mice. (d) In contrast, t-tests indicated that CD8αα
homodimer expression was significantly different on CD8+ CD4+ T cells of the SI LPL and
SI IEL fractions from N/S-BLT and NSG-BLT mice (^SI IEL fractions from three mice
were analyzed, but only two of the three had detectable human T cells and were included in
these analyses.) These differences are represented by lines connecting the arrows above the
respective bars (*P < 0.05; **P < 0.01) reflecting the qualitative differences between these
models demonstrated by the SI T cells in N/S-BLT mice exhibiting an intestine-specific
human surface phenotype.
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Table 2
Absolute numbers of human thymocytes in humanized micea
Thymus analyzed CD8SPb CD4SPb DPc DNd
N/S-BLT
 Human thymic organoid 3.2×107 (1.1×107–2.9×108) 3.0×107 (2.5×106–1.1×108) 6.0×107 (7.0×106–2.1×108) 2.6×106 (4.9×105–2.6×107)
NSG-BLT
 Human thymic organoid 4.3×106 (4.5×103–1.1×107) 9.4×106 (1.2×104–3.7×107) 5.5×107 (4.1×104–1.8×108) 5.9×105 (8.4×103–5.5×106)
 Mouse thymus 2.1×103 (1.2×102–1.8×105) 1.1×104 (1.8×103–5.4×105) 1.9×103 (9.5×102–1.8×106) 1.8×103 (4.5×102–7.4×104)
NSG-hu
 Mouse thymus 1.1×104 (6.9×103–2.5×104) 1.5×104 (8.4×103–3.6×104) 2.7×104 (1.2×104–1.4×105) 3.1×103 (2.9×103–4.2×103)
DKO-hu
 Mouse thymus 3.5×105 (3.8×104–1.0×106) 3.7×105 (2.3×105–4.7×105) 6.2×105 (7.3×104–3.7×106) 8.1×104 (5.9×104–1.3×105)
Abbreviations: BLT, bone marrow liver thymus; DKO, Rag2−/− γ chain−/−; hu, human CD34+ cell bone marrow transplant of newborn mice; N/
S, non-obese diabetic (NOD)/severe-combined immunodeficient (SCID); NSG, NOD/SCID γ chain−/−.
a
Data presented as median with the range within parentheses.
b
SP, single positive for either CD8 or CD4, as indicated.
c
DP, double positive for both CD8 and CD4.
d
DN, double negative for either CD8 or CD4.
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